GE HealthCare Technologies Inc.

GEHC · Healthcare · · USD

68.86 USD

0.00 (-1.23%)

● Updated 2026-09-07 20:35 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score HOLD Long-term (Investment)

/ 100

Technical 40

Trend & RS 39

Momentum 48

Fundamental 63

Macro 64

Liquidity 42

Component	Score	Weight
Technical	40.0	10%
Trend & RS	39.3	10%
Momentum	48.5	5%
Fundamental	62.6	40%
Macro	64.4	15%
Liquidity	42.5	20%

Trade Setup

Entry	68.86
Stop Loss	65.40 (5.0%)
Target 1 (1:1)	72.32 (+5.0%)
Target 2 (2:1)	75.78 (+10.1%)

ATR(14)	1.73 (2.5%)
Risk per Share	3.46
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	73.0	+0.92
Momentum	48.5	-0.06
Quality	39.7	-0.41
Composite	53.7

Quality Scores

Piotroski F-Score 6 /9 — Average

✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 2.93 — Grey Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	15.9	22.0	-28% below
P/B Ratio	2.8	4.0	Below
Dividend Yield	20.0%	1.5%	Above avg

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Intrinsic Value (DCF) Fairly Valued

Intrinsic Value

63.06

Market Price

68.86

Upside

-8.4%

Margin of Safety	-9.2%
Stage 1 PV (5yr FCF)	7,177,110,466
Terminal Value PV	21,307,031,408
Total Enterprise Value	28,484,141,874

Assumptions

Base FCF	1,568,254,667
Growth Rate (5yr)	5.8%
Terminal Growth	2.5%
Discount Rate (WACC)	9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%

Recommended Size

35.08%

Full Kelly

17.54%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 54/100. Estimated win rate 56%, avg win 8.2%, avg loss 3.9%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary SELL

Bullish Signals

Bearish Signals

41.6

RSI(14)

0.3983

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (+1.8% vs SPY 3M)
RS vs Sector	INLINE (Healthcare)
RS New High	No (27d since high)
Sector Outperformance	-1.2% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	41.6	NEUTRAL
Macd	0.3983	BEARISH
Ma Cross	68.28 / 72.68	DEATH CROSS
Trend Short		ABOVE SMA50
Trend Long		BELOW SMA200
Bollinger		LOWER BAND
Volume	1.1x	NORMAL

Key Levels

Level	Price
52-Week High	89.77
Bollinger Upper	75.84
SMA(200)	72.68
SMA(50)	68.28
SMA(20)	72.52
Current Price	68.86
Bollinger Lower	69.19
52-Week Low	58.75
ATR(14)	1.73

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

Insufficient data for Wyckoff analysis.

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-08-31	Normal	1.32x	Normal bar — no special VSA pattern
2026-09-01	Normal	1.08x	Normal bar — no special VSA pattern
2026-09-02	Normal	0.81x	Normal bar — no special VSA pattern
2026-09-03	Normal	1.28x	Normal bar — no special VSA pattern
2026-09-04	Normal	1.1x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	71.44	Above Kijun
Kijun-sen (26)	71.40	Base line
Senkou A	71.42	Leading span A
Senkou B	67.93	Leading span B
Cloud	67.93 – 71.42	Bullish (Green)
Price vs Cloud	68.86	Inside Cloud
Chikou Span	68.02	Bullish
Alignment Score	3/4	NEUTRAL